Description
A Notch inhibitor; induces cell cycle arrest at the G0/G1 phase and decreases MYC and CCNA1 expression in Caki human renal cancer cells; reduces tumor growth and increases survival in a 769-P mouse xenograft model at 8 mg/kg per day
Formal name: N-[(1S)-2-[[(7S)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluoro-butanamide
Synonyms: LY3039478
Molecular weight: 464.4
CAS: 1421438-81-4
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Cycle||Research Area|Cell Biology|Cell Signaling|Notch Signaling